Skip to main content
OpenTrials
Completed

NCT Number: NCT01978886

Prevalence of Unknown and Known Diabetes in Patients With Frozen Shoulder

The purpose of the study is to investigate how high the prevalence of diabetes (known and unknown) is among patients with a frozen shoulder. Our hypothesis is that it is around 30-40 %.

Another purpose is to investigate whether patients with diabetes have a worse and more painful frozen shoulder than patients without diabetes, and whether the diabetes have an influence on the prognosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Amager Hospital, Amager, Copenhagen, Denmark

Loading trial locations.

About this study

Patients who are not diagnosed with diabetes would be ask to give a blood sample to investigate if they have an unknown diabetes.

All patients with frozen shoulder will be asked to fill out a questionnaire (Oxford Shoulder Score) to clarify how bad their frozen shoulder is. All patients will receive the questionnaire 6 and 24 month following the date on inclusion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All newly referred patients who is being diagnosed with frozen shoulder -

Exclusion criteria

age below 25 or above 75, pt. who don't read or understand danish, not danish citizen, patients with mental illness, pt. with a abuse of alcohol or substances, pregnancy, pt. who within 4 months have been injected with adrenocortical hormone, arthrosis in the glenohumeral joint, avascular necrosis of caput humeri, rotator cuff lesion.

-

Treatment and study plan

Primary outcomes

  1. prevalence of known and unknown diabetes diabetes

    Time frame: 1 year

Secondary outcomes

  1. diabetes influence on the prognosis of frozen shoulder

    Time frame: 24 months

    how the status of diabetes influence the prognosis of frozen shoulder. The patient will be asked to fill out oxford shoulder score at the time of inclusion and at 6 and 24 months follow-up. The two groups (patients with and without diabetes) will be compared using the oxford shoulder score.

Sponsors and collaborators

Lead sponsor

Sygehus Lillebaelt

Other

Collaborators

  • Amager Hospital

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Nov 8, 2013
Registry last updated
Feb 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.